Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis have?
Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis has 119 citations in the OpenAlex counts ScholarIQ stores.
When was Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis published?
Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis has 2021 year in the ScholarIQ index.
What is the open-access status of Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis?
Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis has closed oa status in the ScholarIQ index.
What is the DOI of Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis?
The DOI for Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis is on the source record.
What is the PMID of Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis?
The PMID for Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis?
The OpenAlex for Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis is on the source record.